Erythropoietin therapy for children with cerebral palsy
Not Applicable
Recruiting
- Conditions
- Diseases of the nervous system
- Registration Number
- KCT0000482
- Lead Sponsor
- Bundang CHA General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
1) Cerebral Palsy
2) Abnormal Muscle Tone
3) GMFCS (Gross Motor Functional Classification System): II to IV
4) Age: 6 months ~ 3 years
5) Abnormal Brain MRI compatible to clinical features and non-progressive
6) Willing to Comply with All Study Procedure
Exclusion Criteria
1)Known Genetic Disorder
2)Baseline Erythropoietin level > 45 mU/mL
3)Presence of Drug Hypersensitivity Related to the Study Remedy
4)Previous Erythropoietin Treatment before 3 months
5)Coagulopathy
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse Events
- Secondary Outcome Measures
Name Time Method Modified Ashworth Scale;Gross Motor Performance Measure;Gross Motor Function Measure;Bayley Scales of Infant Development, 2nd edition;Alberta Infant Motor Scale